한글목차

최근 맞춤형 유전체학 시장 규모는 급성장하고 있습니다. 2025년 94억 5,000만 달러에서 2026년에는 109억 6,000만 달러에 이르고, CAGR 16.0%의 성장이 전망되고 있습니다. 지난 수년간의 성장에는 유전자 시퀀싱 비용 감소, 만성질환 및 유전질환의 유병률 증가, 연구 기반 유전체 연구의 확대, 진단실험실 인프라 확충, 정밀의료 접근법의 조기 도입 등이 주요 요인으로 작용한 것으로 분석됩니다.

맞춤형 유전체학학 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 15.7%의 연평균 복합 성장률(CAGR)로 196억 1,000만 달러에 이를 전망입니다. 예측 기간 동안의 성장은 유전체학의 일상적인 임상 진료에의 통합, 개인 맞춤형 의료에 대한 수요 증가, 시퀀싱 기술의 발전, 건강 검진 및 조상 검사 확대, 제약 및 생명공학 기업의 투자 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 소비자 대상 유전자 검사 보급 확대, 치료 계획에서 약리유전체학 활용 증가, 예방 및 예측 헬스케어 수요 증가, 생식 의료 분야에서의 유전자 검사 확대, 생활습관 및 건강유전체학에 대한 소비자 인식 개선 등을 들 수 있습니다.

향후 몇 년 동안 만성질환의 유병률 증가가 개인맞춤형 유전체학 시장의 성장을 견인할 것으로 예측됩니다. 만성질환이란 당뇨병, 심혈관질환, 고혈압, 기타 합병증 등 지속적인 관리가 필요한 장기적인 건강상태를 말합니다. 만성질환 증가는 주로 고령화, 운동부족 생활습관, 건강에 해로운 식습관, 여러 질환의 동시 발병에 기여하는 환경적 요인에 기인합니다. 개인 맞춤형 유전체학은 대규모 유전형 분석과 염기서열 분석을 통해 개인을 유전적 위험도에 따라 분류할 수 있게 함으로써 보다 정확한 진단, 표적 치료, 예방 전략의 개선을 지원함으로써 만성질환 관리에 기여할 수 있습니다. 예를 들어, 미국 질병예방통제센터(CDC)의 2025년 4월 기준 자료에 따르면, 미국 성인의 76.4%(약 1억 9,400만 명)가 12가지 특정 만성질환 중 하나 이상을 앓고 있으며, 51.4%(약 1억 3,000만 명)가 두 가지 이상의 질환을 앓고 있는 것으로 나타났습니다. 있었습니다. 따라서 만성질환의 유병률 증가는 개인맞춤형 유전체학 시장의 성장을 가속하고 있습니다.

개인 맞춤형 유전체 시장에서 사업을 전개하는 주요 기업들은 건강, 웰빙, 질병 예방과 관련된 맞춤형 지식을 제공하기 위해 개인 맞춤형 유전체 플랫폼과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 개인 맞춤형 유전체 플랫폼은 개인의 유전정보를 분석하여 건강 상태, 웰니스 최적화, 질병 위험에 대한 개인 맞춤형 추천 및 지식을 제공하는 시스템입니다. 예를 들어, 2024년 9월 인도에 본사를 둔 진단 서비스 기업인 Neuberg Diagnostics Private Limited는 맞춤형 유전체 플랫폼 'Geniee Decode Your DNA'를 발표했습니다. 이 개인화 유전체 플랫폼은 개인의 유전자 프로파일을 기반으로 개인화된 건강, 영양, 약물에 대한 지식을 제공하여 웰니스 최적화, 질병 예방, 치료의 개인화를 통한 건강 상태 개선을 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Personalized genomics refers to the application of an individual's genetic data to customize medical care, lifestyle guidance, and disease risk evaluations based on their unique DNA makeup. It is used in areas such as predicting disease susceptibility, optimizing drug response, and supporting preventive healthcare approaches.

The main test types in personalized genomics include oncology testing, infectious disease testing, neurological testing, cardiovascular testing, and other categories. Oncology testing comprises diagnostic procedures used to detect, diagnose, and monitor cancer through genetic, molecular, and imaging techniques. The technologies utilized in oncology testing include polymerase chain reaction (PCR)-based tests, microarray-based assays, sequencing-based tests, and other advanced methods. These tests are applied across areas such as diagnostics, precision medicine, wellness, reproductive health, sports nutrition, lifestyle management, and others, and they serve end users including hospitals, clinics, research institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, and other organizations.

Tariffs have influenced the personalized genomics market by increasing costs for imported sequencing instruments, reagents, and testing consumables, impacting overall test pricing. Sequencing-based tests and advanced molecular technologies are most affected, particularly in regions dependent on imports such as Asia-Pacific and parts of Europe. These cost pressures can slow adoption in diagnostics and wellness applications. However, tariffs are also encouraging domestic manufacturing, local innovation, and regional capacity building for genomics technologies.

The personalized genomics market research report is one of a series of new reports from The Business Research Company that provides personalized genomics market statistics, including personalized genomics industry global market size, regional shares, competitors with a personalized genomics market share, detailed personalized genomics market segments, market trends and opportunities, and any further data you may need to thrive in the personalized genomics industry. This personalized genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized genomics market size has grown rapidly in recent years. It will grow from $9.45 billion in 2025 to $10.96 billion in 2026 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to declining costs of genetic sequencing, increasing prevalence of chronic and genetic diseases, growth in research-based genomics studies, expansion of diagnostic laboratory infrastructure, early adoption of precision medicine approaches.

The personalized genomics market size is expected to see rapid growth in the next few years. It will grow to $19.61 billion in 2030 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to integration of genomics into routine clinical practice, rising demand for personalized medicine, advancements in sequencing technologies, expansion of wellness and ancestry testing, growing investments by pharmaceutical and biotechnology companies. Major trends in the forecast period include rising adoption of direct-to-consumer genetic testing, growing use of pharmacogenomics in treatment planning, increasing demand for preventive and predictive healthcare, expansion of genetic testing in reproductive health, rising consumer awareness of lifestyle and wellness genomics.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the personalized genomics market in the coming years. Chronic diseases are long-term health conditions that require continuous management and include diabetes, cardiovascular diseases, hypertension, and other complex disorders. The rise in chronic diseases is mainly attributed to aging populations, sedentary lifestyles, unhealthy dietary patterns, and environmental influences that contribute to the simultaneous development of multiple conditions. Personalized genomics aids chronic disease management by enabling large-scale genotyping and sequencing to categorize individuals based on genetic risk, supporting more accurate diagnoses, targeted treatments, and improved preventive strategies. For instance, in April 2025, according to the U.S. Centers for Disease Control and Prevention (CDC), a US-based organization, 76.4% of U.S. adults-approximately 194 million people-had at least one of 12 selected chronic conditions, while 51.4% (around 130 million individuals) were living with two or more of these conditions. Therefore, the rising prevalence of chronic diseases is fueling the growth of the personalized genomics market.

Major companies operating in the personalized genomics market are concentrating on the development of innovative solutions, such as personalized genomics platforms, to deliver customized insights related to health, wellness, and disease prevention. A personalized genomics platform is a system designed to analyze an individual's genetic information and provide tailored recommendations and insights concerning health status, wellness optimization, and disease risk. For example, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic services company, launched Geniee Decode Your DNA, a customized genomics platform. This personalized genomics platform delivers individualized health, nutrition, and medication insights based on a person's genetic profile, helping to optimize wellness, prevent disease, and personalize treatments for improved health outcomes.

In August 2024, Labcorp, a US-based diagnostics and laboratory services company, acquired selected assets of Invitae Corporation for an undisclosed amount. Through this acquisition, Labcorp seeks to enhance its specialty testing portfolio and strengthen the use of genetic data to advance clinical trials and personalized care in oncology and rare disease areas. Invitae Corporation is a US-based medical genetics company specializing in comprehensive genetic testing and genomic data services.

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized genomics market consists of revenues earned by entities by providing services such as pharmacogenomic services, genetic counseling, and customized fitness plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized genomics market also includes sales of genetic testing kits, health risk assessments, and nutrigenomics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Genomics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses personalized genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Test Type: Oncology Testing; Neurological Testing; Cardiovascular Testing; Other Test Types
• 2) By Technology: Polymerase Chain Reaction-Based Tests; Microarray-Based Tests; Sequencing-Based Tests; Other Technologies
• 3) By Application: Diagnostics; Precision Medicine; Wellness; Reproductive Health; Sports Nutrition And Health; Lifestyle; Other Applications
• 4) By End User: Hospitals And Clinics; Research Centers; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Oncology Testing: Liquid Biopsy; Tumor Profiling; Genetic Testing For Cancer Risk; Companion Diagnostics
• 2) By Neurological Testing: Alzheimer's Disease Testing; Huntington's Disease Testing; Parkinson's Disease Testing; Epilepsy Testing
• 3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases; Arrhythmia Testing; Coronary Artery Disease Testing
• 4) By Other Test Types: Pharmacogenomics Testing; Genetic Screening For Inherited Disorders; Ancestry Testing
• Companies Mentioned: Thermo Fisher Scientific Inc.; Illumina Inc.; Myriad Genetics Inc.; BGI Genomics Co. Ltd.; Invitae Corporation; Guardant Health Inc.; GeneDx LLC; Ancestry Inc.; Oxford Nanopore Technologies plc; Genomic Health Inc.; 23andMe Holding Co.; Color Health Inc.; Helix OpCo LLC; Personalis Inc.; Dante Genomics; Gene By Gene Ltd.; Veritas Genetics Inc.; Futura Genetics; Nebula Genomics Inc.; Pathway Genomics Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Personalized Genomics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Personalized Genomics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Personalized Genomics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Personalized Genomics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Direct-To-Consumer Genetic Testing
  • 4.2.2 Growing Use Of Pharmacogenomics In Treatment Planning
  • 4.2.3 Increasing Demand For Preventive And Predictive Healthcare
  • 4.2.4 Expansion Of Genetic Testing In Reproductive Health
  • 4.2.5 Rising Consumer Awareness Of Lifestyle And Wellness Genomics

5. Personalized Genomics Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Diagnostic Laboratories
• 5.3 Pharmaceutical And Biotechnology Companies
• 5.4 Research Centers
• 5.5 Wellness And Consumer Genomics Companies

6. Personalized Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Personalized Genomics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Personalized Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Personalized Genomics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Personalized Genomics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Personalized Genomics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Personalized Genomics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Personalized Genomics Market Segmentation

• 9.1. Global Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types
• 9.2. Global Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies
• 9.3. Global Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications
• 9.4. Global Personalized Genomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users
• 9.5. Global Personalized Genomics Market, Sub-Segmentation Of Oncology Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics
• 9.6. Global Personalized Genomics Market, Sub-Segmentation Of Neurological Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Alzheimer's Disease Testing, Huntington's Disease Testing, Parkinson's Disease Testing, Epilepsy Testing
• 9.7. Global Personalized Genomics Market, Sub-Segmentation Of Cardiovascular Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing
• 9.8. Global Personalized Genomics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

10. Personalized Genomics Market Regional And Country Analysis

• 10.1. Global Personalized Genomics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Personalized Genomics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Personalized Genomics Market

• 11.1. Asia-Pacific Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Personalized Genomics Market

• 12.1. China Personalized Genomics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Personalized Genomics Market

• 13.1. India Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Personalized Genomics Market

• 14.1. Japan Personalized Genomics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Personalized Genomics Market

• 15.1. Australia Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Personalized Genomics Market

• 16.1. Indonesia Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Personalized Genomics Market

• 17.1. South Korea Personalized Genomics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Personalized Genomics Market

• 18.1. Taiwan Personalized Genomics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Personalized Genomics Market

• 19.1. South East Asia Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Personalized Genomics Market

• 20.1. Western Europe Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Personalized Genomics Market

• 21.1. UK Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Personalized Genomics Market

• 22.1. Germany Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Personalized Genomics Market

• 23.1. France Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Personalized Genomics Market

• 24.1. Italy Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Personalized Genomics Market

• 25.1. Spain Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Personalized Genomics Market

• 26.1. Eastern Europe Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Personalized Genomics Market

• 27.1. Russia Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Personalized Genomics Market

• 28.1. North America Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Personalized Genomics Market

• 29.1. USA Personalized Genomics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Personalized Genomics Market

• 30.1. Canada Personalized Genomics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Personalized Genomics Market

• 31.1. South America Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Personalized Genomics Market

• 32.1. Brazil Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Personalized Genomics Market

• 33.1. Middle East Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Personalized Genomics Market

• 34.1. Africa Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Personalized Genomics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Personalized Genomics Market Regulatory and Investment Landscape

36. Personalized Genomics Market Competitive Landscape And Company Profiles

• 36.1. Personalized Genomics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Personalized Genomics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Personalized Genomics Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. BGI Genomics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Personalized Genomics Market Other Major And Innovative Companies

• Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

38. Global Personalized Genomics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Personalized Genomics Market

40. Personalized Genomics Market High Potential Countries, Segments and Strategies

• 40.1 Personalized Genomics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Personalized Genomics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Personalized Genomics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer